TOMORROW’S TECHNOLOGY,
TODAY’S CURE.

  • Targeted intravenous delivery of therapeutic payload to the tumor
  • Stimulate anti-tumor immune response
  • Overcome the tumor’s immunosuppressive capabilities
  • Overcome anti-viral immune response for effective repeat treatment

KALIVIR’S
DEVELOPMENT
PIPELINE